BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 32128927)

  • 1. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
    Sweidan W; Bao F; Bozorgzad NS; George E
    J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington's disease patients.
    Ramirez-Garcia G; Galvez V; Diaz R; Bayliss L; Fernandez-Ruiz J; Campos-Romo A
    Eur J Neurosci; 2020 Apr; 51(8):1827-1843. PubMed ID: 31705594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
    Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
    Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural brain correlates of dementia in Huntington's disease.
    Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
    Neuroimage Clin; 2020; 28():102415. PubMed ID: 32979842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.
    Minkova L; Gregory S; Scahill RI; Abdulkadir A; Kaller CP; Peter J; Long JD; Stout JC; Reilmann R; Roos RA; Durr A; Leavitt BR; Tabrizi SJ; Klöppel S;
    Neuroimage Clin; 2018; 17():312-324. PubMed ID: 29527479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking white matter and deep gray matter alterations in premanifest Huntington disease.
    Faria AV; Ratnanather JT; Tward DJ; Lee DS; van den Noort F; Wu D; Brown T; Johnson H; Paulsen JS; Ross CA; Younes L; Miller MI;
    Neuroimage Clin; 2016; 11():450-460. PubMed ID: 27104139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.
    Chen L; Hua J; Ross CA; Cai S; van Zijl PCM; Li X
    J Neurosci Res; 2019 Apr; 97(4):467-479. PubMed ID: 30489648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
    Rosas HD; Tuch DS; Hevelone ND; Zaleta AK; Vangel M; Hersch SM; Salat DH
    Mov Disord; 2006 Sep; 21(9):1317-25. PubMed ID: 16755582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin Breakdown in Human Huntington's Disease: Multi-Modal Evidence from Diffusion MRI and Quantitative Magnetization Transfer.
    Bourbon-Teles J; Bells S; Jones DK; Coulthard E; Rosser A; Metzler-Baddeley C
    Neuroscience; 2019 Apr; 403():79-92. PubMed ID: 28579146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B; Wen J; Cross AH; Yablonskiy DA
    J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive alterations in white matter microstructure across the timecourse of Huntington's disease.
    Estevez-Fraga C; Elmalem MS; Papoutsi M; Durr A; Rees EM; Hobbs NZ; Roos RAC; Landwehrmeyer B; Leavitt BR; Langbehn DR; Scahill RI; Rees G; Tabrizi SJ; Gregory S
    Brain Behav; 2023 Apr; 13(4):e2940. PubMed ID: 36917716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease.
    Inguanzo A; Sala-Llonch R; Segura B; Erostarbe H; Abos A; Campabadal A; Uribe C; Baggio HC; Compta Y; Marti MJ; Valldeoriola F; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2021 Jan; 82():16-23. PubMed ID: 33227683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.
    Labayru G; Diez I; Sepulcre J; Fernández E; Zulaica M; Cortés JM; López de Munain A; Sistiaga A
    Neuroimage Clin; 2019; 24():102078. PubMed ID: 31795042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington's disease.
    Hu B; Younes L; Bu X; Liu CF; Ratnanather JT; Paulsen J; Georgiou-Karistianis N; Miller MI; Ross C; Faria AV
    Neuroimage Clin; 2023; 39():103493. PubMed ID: 37582307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington's disease: the IMAGE-HD study.
    Tan B; Shishegar R; Oldham S; Fornito A; Poudel G; Georgiou-Karistianis N
    Brain Imaging Behav; 2022 Dec; 16(6):2457-2466. PubMed ID: 35768755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilament light protein in blood predicts regional atrophy in Huntington disease.
    Johnson EB; Byrne LM; Gregory S; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RA; Zetterberg H; Tabrizi SJ; Scahill RI; Wild EJ;
    Neurology; 2018 Feb; 90(8):e717-e723. PubMed ID: 29367444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
    Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
    Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.